A61K 31/4747
Spiro-condensed
Official title: spiro-condensed
A61K31/4747 (Spiro-condensed) appears on 79 US grants and 158 published applications in this corpus.
Search patents in A61K- Granted patents
- 79
- Published applications
- 158
- Assignees
- 87
- Inventors
- 414
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 1 |
| 2002 | 5 | 4 |
| 2003 | 2 | 9 |
| 2004 | 2 | 11 |
| 2005 | 1 | 8 |
| 2006 | 2 | 20 |
| 2007 | 2 | 11 |
| 2008 | 3 | 4 |
| 2009 | 2 | 4 |
| 2010 | 2 | 3 |
| 2011 | 8 | 4 |
| 2012 | 4 | 4 |
| 2013 | 6 | 8 |
| 2014 | 5 | 13 |
| 2015 | 9 | 8 |
| 2016 | 4 | 7 |
| 2017 | 3 | 1 |
| 2018 | 4 | 3 |
| 2019 | 2 | 4 |
| 2020 | 2 | 2 |
| 2021 | 1 | 1 |
| 2022 | 1 | 6 |
| 2023 | 0 | 3 |
| 2024 | 1 | 3 |
| 2025 | 3 | 9 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Spiros and related analogs for inhibiting YAP/TAZ-TEAD7 Jul 2026US 12,673,950 B2Katholieke Universiteit Leuven
- Osmotic dosage forms comprising deutetrabenazine and methods of use thereof31 Mar 2026US 12,589,075 B2Auspex Pharmaceuticals, Inc.
- Kinase inhibitors and methods of use thereof23 Sep 2025US 12,419,885 B2Dana-Farber Cancer Institute, Inc.
- Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use18 Feb 2025US 12,226,405 B2Novartis AG
- Methods of treating epilepsy7 Jan 2025US 12,186,307 B2Yale University
- Spirocyclic linked tricyclic compounds10 Sep 2026US 2026/0265266 A1Sub21, Inc.
- Heterocyclic compounds as pi3ka inhibitors6 Aug 2026US 2026/0226010 A1Pikavation Therapeutics, Inc.
- Combination therapies for treatment of hearing disorders23 Jul 2026US 2026/0207616 A1Gateway Biotechnology, Inc.
- Pyridine polycyclic compound inhibitor, preparation method therefor and use thereof16 Jul 2026US 2026/0200931 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Heterocyclic compounds, preparation methods and uses thereof2 Jul 2026US 2026/0184692 A1Inventisbio Co., Ltd.
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Modulators of ATP-binding cassette transporters105US 8,101,767 B2Vertex Pharmaceuticals Incorporated · 2012
- Modulators of ATP-binding cassette transporters97US 8,324,242 B2Vertex Pharmaceutical Incorporated · 2012
- Neural tourniquet76US 8,729,129 B2The Feinstein Institute for Medical Research · 2014
- Modulators of ATP-binding cassette transporters74US 8,629,162 B2Vertex Pharmaceuticals Incorporated · 2014